世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
酸素療法市場。世界の産業動向、シェア、サイズ、成長、機会、および2021-2026年の予測Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global oxygen therapy market exhibited strong growth during 2015-2020. Oxygen therapy, or supplemental oxygen, refers to a medical treatment that involves using an additional oxygen source to m... もっと見る
サマリーThe global oxygen therapy market exhibited strong growth during 2015-2020. Oxygen therapy, or supplemental oxygen, refers to a medical treatment that involves using an additional oxygen source to manage the blood oxygen levels and prevent carbon monoxide toxicity. It is commonly used for conditions, such as hypoxia, hypoxemia, pneumonia and asthma. Oxygen is administered in liquid or gaseous form, which is transferred through a cannula, face mask or hyperbaric oxygen chamber. They are also attached to other medical devices, such as ventilators and continuous positive airway pressure machines, to improve the efficiency of the treatment. Healthcare centers are also using novel portable tanks and oxygen concentrators to provide point-of-care (POC) and convenient oxygen therapy treatments to the patients.The increasing prevalence of various respiratory disorders, such as pneumonia, cystic fibrosis, asthma, dysplasia and sleep apnea, across the globe is one of the key factors creating a positive outlook for the market growth. Oxygen therapy is used to improve the transfer of oxygen from alveoli to the blood, cell metabolism and tissue oxygenation, which are essential for normal physiological functioning. Furthermore, increasing consumption of nicotine and tobacco products, along with the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Additionally, the development of cost-effective, rapid and accurate oxygen therapy devices and the increasing preference for oxygen therapy among doctors, physicians, surgeons and patients are also creating a positive outlook for the market. Other factors, including rising healthcare expenditure capacities, along with extensive research and development (R&D) activities, are anticipated to drive the market further. Looking forward, IMARC Group expects the global oxygen therapy market to grow at a CAGR of around 10% during the forecast period (2021-2026). Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global oxygen therapy market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and end use. Breakup by Product: Oxygen Source Equipment Oxygen Cylinders Oxygen Concentrators Liquid Oxygen Devices PAP Devices Oxygen Delivery Devices Oxygen Masks Nasal Cannula Venturi Masks Non-rebreather Masks Bag Valve Masks CPAP Masks Others Breakup by Application: Chronic Obstructive Pulmonary Disease Asthma Obstructive Sleep Apnea Respiratory Distress Syndrome Cystic Fibrosis Pneumonia Others Breakup by End Use: Home Healthcare Hospitals Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A., and Teleflex Incorporated. Key Questions Answered in This Report: How has the global oxygen therapy market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global oxygen therapy market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global oxygen therapy market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Oxygen Therapy Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Oxygen Source Equipment 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 Oxygen Cylinders 6.1.2.2 Oxygen Concentrators 6.1.2.3 Liquid Oxygen Devices 6.1.2.4 PAP Devices 6.1.3 Market Forecast 6.2 Oxygen Delivery Devices 6.2.1 Market Trends 6.2.2 Key Segments 6.2.2.1 Oxygen Masks 6.2.2.2 Nasal Cannula 6.2.2.3 Venturi Masks 6.2.2.4 Non-rebreather Masks 6.2.2.5 Bag Valve Masks 6.2.2.6 CPAP Masks 6.2.2.7 Others 6.2.3 Market Forecast 7 Market Breakup by Application 7.1 Chronic Obstructive Pulmonary Disease 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Asthma 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Obstructive Sleep Apnea 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Respiratory Distress Syndrome 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Cystic Fibrosis 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Pneumonia 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Others 7.7.1 Market Trends 7.7.2 Market Forecast 8 Market Breakup by End Use 8.1 Home Healthcare 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Hospitals 8.2.1 Market Trends 8.2.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Allied Healthcare Products Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Becton Dickinson and Company 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.) 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Fisher & Paykel Healthcare Limited 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.5 General Electric Company 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Getinge AB 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Hersill SL 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Invacare Corporation 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Koninklijke Philips N.V 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 Smiths Group plc 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis 14.3.11 Tecno-Gaz S.p.A. 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.12 Teleflex Incorporated 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.12.3 Financials 14.3.12.4 SWOT Analysis
SummaryThe global oxygen therapy market exhibited strong growth during 2015-2020. Oxygen therapy, or supplemental oxygen, refers to a medical treatment that involves using an additional oxygen source to manage the blood oxygen levels and prevent carbon monoxide toxicity. It is commonly used for conditions, such as hypoxia, hypoxemia, pneumonia and asthma. Oxygen is administered in liquid or gaseous form, which is transferred through a cannula, face mask or hyperbaric oxygen chamber. They are also attached to other medical devices, such as ventilators and continuous positive airway pressure machines, to improve the efficiency of the treatment. Healthcare centers are also using novel portable tanks and oxygen concentrators to provide point-of-care (POC) and convenient oxygen therapy treatments to the patients.The increasing prevalence of various respiratory disorders, such as pneumonia, cystic fibrosis, asthma, dysplasia and sleep apnea, across the globe is one of the key factors creating a positive outlook for the market growth. Oxygen therapy is used to improve the transfer of oxygen from alveoli to the blood, cell metabolism and tissue oxygenation, which are essential for normal physiological functioning. Furthermore, increasing consumption of nicotine and tobacco products, along with the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Additionally, the development of cost-effective, rapid and accurate oxygen therapy devices and the increasing preference for oxygen therapy among doctors, physicians, surgeons and patients are also creating a positive outlook for the market. Other factors, including rising healthcare expenditure capacities, along with extensive research and development (R&D) activities, are anticipated to drive the market further. Looking forward, IMARC Group expects the global oxygen therapy market to grow at a CAGR of around 10% during the forecast period (2021-2026). Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global oxygen therapy market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and end use. Breakup by Product: Oxygen Source Equipment Oxygen Cylinders Oxygen Concentrators Liquid Oxygen Devices PAP Devices Oxygen Delivery Devices Oxygen Masks Nasal Cannula Venturi Masks Non-rebreather Masks Bag Valve Masks CPAP Masks Others Breakup by Application: Chronic Obstructive Pulmonary Disease Asthma Obstructive Sleep Apnea Respiratory Distress Syndrome Cystic Fibrosis Pneumonia Others Breakup by End Use: Home Healthcare Hospitals Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A., and Teleflex Incorporated. Key Questions Answered in This Report: How has the global oxygen therapy market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global oxygen therapy market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global oxygen therapy market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Oxygen Therapy Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Oxygen Source Equipment 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 Oxygen Cylinders 6.1.2.2 Oxygen Concentrators 6.1.2.3 Liquid Oxygen Devices 6.1.2.4 PAP Devices 6.1.3 Market Forecast 6.2 Oxygen Delivery Devices 6.2.1 Market Trends 6.2.2 Key Segments 6.2.2.1 Oxygen Masks 6.2.2.2 Nasal Cannula 6.2.2.3 Venturi Masks 6.2.2.4 Non-rebreather Masks 6.2.2.5 Bag Valve Masks 6.2.2.6 CPAP Masks 6.2.2.7 Others 6.2.3 Market Forecast 7 Market Breakup by Application 7.1 Chronic Obstructive Pulmonary Disease 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Asthma 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Obstructive Sleep Apnea 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Respiratory Distress Syndrome 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Cystic Fibrosis 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Pneumonia 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Others 7.7.1 Market Trends 7.7.2 Market Forecast 8 Market Breakup by End Use 8.1 Home Healthcare 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Hospitals 8.2.1 Market Trends 8.2.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Allied Healthcare Products Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Becton Dickinson and Company 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.) 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Fisher & Paykel Healthcare Limited 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.5 General Electric Company 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Getinge AB 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Hersill SL 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Invacare Corporation 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Koninklijke Philips N.V 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 Smiths Group plc 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis 14.3.11 Tecno-Gaz S.p.A. 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.12 Teleflex Incorporated 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.12.3 Financials 14.3.12.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（産業機械）の最新刊レポート
IMARC Services Private Limited.社のその他分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/19 10:26 155.48 円 165.11 円 199.74 円 |
